agmatine has been researched along with Amphetamine-Related Disorders in 2 studies
Agmatine: Decarboxylated arginine, isolated from several plant and animal sources, e.g., pollen, ergot, herring sperm, octopus muscle.
Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.
Excerpt | Relevance | Reference |
---|---|---|
"Methamphetamine abuse remains an alarming public heath challenge, with no approved pharmacotherapies available." | 3.83 | Agmatine attenuates the discriminative stimulus and hyperthermic effects of methamphetamine in male rats. ( Li, J; Li, JX; Qiu, Y; Thorn, DA, 2016) |
"Agmatine pretreatment alone had no effects on locomotion or stereotypy, but it produced a dose-dependent attenuation of locomotion and the total incidence of stereotyped behavior induced by a low dose of METH (5 mg/kg)." | 1.40 | Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice. ( Hall, FS; Kitanaka, J; Kitanaka, N; Kubo, H; Nishiyama, N; Takahashi, H; Takemura, M; Tanaka, K; Uhl, GR; Watabe, K, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kitanaka, N | 1 |
Kitanaka, J | 1 |
Hall, FS | 1 |
Uhl, GR | 1 |
Watabe, K | 1 |
Kubo, H | 1 |
Takahashi, H | 1 |
Tanaka, K | 1 |
Nishiyama, N | 1 |
Takemura, M | 1 |
Thorn, DA | 1 |
Li, J | 1 |
Qiu, Y | 1 |
Li, JX | 1 |
2 other studies available for agmatine and Amphetamine-Related Disorders
Article | Year |
---|---|
Agmatine attenuates methamphetamine-induced hyperlocomotion and stereotyped behavior in mice.
Topics: Agmatine; Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Dose-Response R | 2014 |
Agmatine attenuates the discriminative stimulus and hyperthermic effects of methamphetamine in male rats.
Topics: Agmatine; Amphetamine-Related Disorders; Animals; Discrimination Learning; Dopamine Antagonists; Dos | 2016 |